Tag

doudna

Gene-editing pipeline takes off

Clinical trials of genome-editing agents — including CRISPR–Cas9 editors, zinc finger nucleases and TALENs — are pushing ex vivo, immuno-oncology and in vivo treatment frontiers.   Focus CRISPR Client UC Berkeley READ THE ...

Coronavirus: a world transformed

Paul Laudicina at Kearney’s Global Business Policy Council interviews CRISPR pioneer Dr. Jennifer Doudna who is doing new work to understand and slow the spread of COVID-19. They discuss the ...

How the coronavirus will transform science

From the moment the world heard about a novel coronavirus, known now as SARS-CoV-2, causing widespread respiratory illnesses in China, scientists leapt into action. Academic, government, and industry labs mobilized ...

U.C. Berkeley Opens COVID-19 Testing Lab

Jennifer Doudna, biochemist at University of California at Berkeley and CRISPR co-inventor, discusses the partnership between the Innovative Genomic Institute and the university to run rapid response testing during ...

C&EN’s 2020 Trailblazers

In total, the women profiled in C&EN's 2020 Trailblazers have launched more than 30 start-ups aimed at developing treatments for rare diseases, building better batteries, and more. They’re scientists ...

Expanding the CRISPR Toolbox

If your only CRISPR tool is an ordinary Cas9 enzyme, you might imagine that every genome editing problem has the same solution, a blunt double-strand break. Fortunately, ordinary Cas9 ...

The Long View On Gene Editing

It began as an effort to understand how microbes fight viral infections. Within their chromosomes bacteria store snippets of DNA taken from the viruses they encounter. These fragments, which ...

25 Ideas That Will Shape the 2020s

Will paper money disappear? Will gene-tailored medicine transform how we treat disease? And will you finally trade in that juicy steak for “cell grown” meat? As a new decade begins, ...

Year in Pharma 2019

It was a bustling year for the drug industry, filled with acquisitions, substantial investment in promising technologies, and a steady stream of new drug approvals. Pharma behemoths merged, forming even ...

CRISPR’s unwanted anniversary

There are key moments in the history of every disruptive technology that can make or break its public perception and acceptance. For CRISPR-based genome editing, such a moment occurred ...

The 2010s: A Decade in Review

The first decade of the 21st century introduced us to sweeping mobile and social revolutions largely driven by names like Jobs, Zuckerberg and Bezos. In the second decade that's now ...

From IVF to Gene Surgery

The first “test-tube baby” is now more than 40 years old, and all is well with her. Millions more babies have followed by means of in vitro fertilization, or ...
13

This is a unique website which will require a more modern browser to work!

Please upgrade today!